Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-24
2008-12-23
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S358000, C544S359000, C544S366000, C544S371000, C548S356100, C548S358100, C548S359100, C514S252120, C514S254010, C514S403000, C514S406000
Reexamination Certificate
active
07468371
ABSTRACT:
Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
REFERENCES:
patent: 6291504 (2001-09-01), Nugiel et al.
patent: 6297238 (2001-10-01), Doyle et al.
patent: 6407103 (2002-06-01), Doyle et al.
patent: 6462036 (2002-10-01), Doyle et al.
patent: 2001/0027195 (2001-10-01), Nugiel et al.
patent: 99/54308 (1999-10-01), None
patent: 00/27822 (2000-05-01), None
patent: 00/59901 (2000-10-01), None
patent: 01/87846 (2001-11-01), None
patent: 02/44174 (2002-06-01), None
patent: 02/46182 (2002-06-01), None
patent: 02/070494 (2002-09-01), None
patent: 03/004491 (2003-01-01), None
patent: 03/007883 (2003-01-01), None
patent: 03/033499 (2003-04-01), None
patent: 03/070236 (2003-08-01), None
Nugiel et al., “Indenopyrazoles as Novel Cyclin Dependent Kinase (CDK) Inhibitors,” J. Med. Chem. 44:1334-1336 (2001).
Nugiel et al., “Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 2. Probing the Indeno Ring Substitutent Pattern,” J. Med. Chem. 46:5224-5232 (2002).
Yue et al., “Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 3. Structure Activity Relationships as C31,2,” J. Med. Chem. 45:5233-5248 (2002).
Akritopoulou-Zanze Irini
Arnold Lee D.
Dinges Jürgen
Dixon Richard W.
Djuric Stevan W.
Abbott Laboratories Inc.
Donner B. Gregory
Shameem Golam M. M.
LandOfFree
Tricyclic pyrazole kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic pyrazole kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic pyrazole kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4026535